Response and long-term control of bone metastases after peptide receptor radionuclide therapy with (177)Lu-octreotate

Publisher DOI
PubMed ID
21764798
Description
Peptide receptor radionuclide therapy (PRRT) is an efficient treatment for gastroenteropancreatic neuroendocrine tumors (GEP NETs), with outstanding overall response rates and survival. However, little is known about the particular efficacy regarding bone metastasis (BM).
Date of Publication
2011
Publication Type
Article
Language(s)
en
Contributor(s)
Ezziddin, Samer
Sabet, Amir
Heinemann, Florian
Yong-Hing, Charlotte J
Ahmadzadehfar, Hojjat
Guhlke, Stefan
Höller, Tobias
Willinek, Winfried
Biersack, Hans-Jürgen
Additional Credits
Series
Journal of nuclear medicine
Publisher
Society of Nuclear Medicine
ISSN
0161-5505
Access(Rights)
metadata.only
Show full item